22 May 2013
Keywords: promising, new, data, gsk, nelarabine, results, presented
Article | 22 December 2003
Results presented at the 45th Annual Meeting of the American Society ofHematology in San Diego, California, showed that GlaxoSmithKline's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2003
© 2013 thepharmaletter.com